Follicle-stimulating hormone (FSH) and oocyte-secreted factors influence granulosa cell differentiation and follicle development. Whereas FSH stimulates the expression of mural cell transcripts, oocyte-secreted factors regulate specific cumulus cell genes and suppress the appearance of mural cell transcripts. This study addresses the extent to which clinically relevant changes in FSH doses applied during antral follicle development in vitro could alter the expression of oocyte and cumulus cell transcripts. A 12-day culture system in which mouse ovarian preantral follicles can grow to preovulatory follicles was used. The following three FSH regimens were considered: 1) continuous exposure to an FSH level of 10 mIU/ ml (control), 2) decreasing concentrations of FSH (low FSH), and 3) an FSH level of 25 mIU/ml (high FSH) as soon as the antrum is formed. Transcripts in oocytes (Gdf9, Bmp15, and Fgf8) and in cumulus cells (Amh, Lhcgr, Ar, and Pfkp) were quantified by real-time PCR. Under high FSH, the three oocyte transcripts were upregulated, while in cumulus cells a shutdown of the Amh signal and substantial increases in Lhcgr and Ar expression were measured. In contrast, low FSH tended to reduce Lhcgr to levels comparable to those in vivo. Levels of Pfkp were not affected by FSH doses. These results demonstrate that a 2.5-fold increase in FSH changes both oocyte and cumulus cell transcript levels. Conversely, a decrease in FSH does not affect transcript levels but seems to limit inappropriate Lhcgr expression. Modulating FSH within physiological ranges during the antral phase of culture alters cumulus cell differentiation.
INTRODUCTION
Developmental competence of oocytes is gained gradually during folliculogenesis and depends on the interaction with their companion somatic cells [1] [2] [3] . Communication between an oocyte and its surrounding granulosa cells is essential for oocyte growth and cumulus cell differentiation [4, 5] .
Paracrine factors secreted by the oocyte have been shown to regulate granulosa cell functions such as proliferation, differentiation, cumulus expansion, steroidogenesis, and glucose metabolism [6] [7] [8] . Two well-known members of the transforming growth factor-beta superfamily (growth differentiation factor 9 [GDF9] and bone morphogenetic protein 15 [BMP15]) are important oocyte-secreted factors thought to act synergistically in granulosa cell proliferation, development, and function of the cumulus-oocyte complex (COC) [9] . Fibroblast growth factor 8 (FGF8) also has a role in the growth and differentiation of granulosa cells [10] . Moreover, both BMP15 and FGF8 were shown to cooperate in promoting glycolysis in cumulus cells by stimulating the expression of genes such as phosphofructokinase platelet (Pfkp) [11] and Llactate dehydrogenase (Ldha) [12] . Table 1 gives a description of selected genes.
Antimüllerian hormone (Amh), solute carrier (Slc38a3), and androgen receptor (Ar) are cumulus cell markers of differentiation shown to be regulated by oocyte factors [5, 13, 14] . Follicle-stimulating hormone (FSH) is known to regulate the proliferation and differentiation of granulosa cells in early preantral follicles, stimulating the expression of mural cell markers such as Lhcgr (luteinizing hormone/choriogonadotropin receptor) [5, 15, 16] . In vitro findings have demonstrated that FSH suppresses some phenotypic characteristics of cumulus cells such as the expression of Slc38a3 and Ar [5] . On the other hand, oocyte-secreted factors suppress the expression of mural cell markers such as Lhcgr in cumulus cells [5, 17] .
Follicles grown under high concentrations of insulin and FSH have been shown to result in inappropriate differentiation of cumulus cells, causing poor oocyte developmental competence [18] . Furthermore, Bmp15 (but not Gdf9) mRNA levels were shown to increase in COCs of gonadotropin-treated immature mice [19] . An influence of FSH on the expression of cumulus cell markers has been reported [5] , although the effect of FSH on oocyte gene expression has not been analyzed in great detail.
It remains to be investigated in human assisted reproductive technology (ART) whether incremental doses of FSH and/or so-called FSH coasting during superovulation might affect key genes in the COC. For obvious ethical reasons, such a study is impossible in humans. As an initial approach to this question, FSH dose regimens were applied to a well-standardized in vitro mouse follicle culture model [20] .
The objective of this study was to analyze changes in gene expression in oocytes and corresponding cumulus cells from follicles exposed to FSH dose regimens during the antral growth period that would somewhat mimic dose regimens clinical practice [21, 22] . Gdf9, Bmp15, and Fgf8 mRNA content was quantified in oocytes, while Amh, Ar, Pfkp, and Lhcgr mRNA amounts were quantified in the corresponding cumulus cells.
MATERIALS AND METHODS

Follicle Culture
Female mice housed and bred according to national legislation were used for this study. The study protocol was approved by the institutional ethical committee for animal experiments of Vrije Universiteit Brussel (project 01-395-1).
Mouse ovarian preantral follicles from 13-day-old female mouse (F1 hybrids of C57BL/6J 3 CBA/Ca) ovaries were aseptically isolated and grown as described earlier [20] but with some exceptions. Refreshment of medium was performed every 3 days by taking out 30 ll of spent medium and replacing it with 30 ll of fresh culture medium. In this culture system, the minimum FSH dose effective for maximum follicle survival and differentiation was 10 mIU/ ml, and its prolonged omission during the early preantral stage compromised oocyte developmental competence [23] . From Day 6 (the onset of antral-like cavity formation) onward, follicles were exposed to the following three different FSH conditions: 1) constant exposure to an FSH level of 10 mIU/ml (control), 2) a continuous decrease in FSH (low FSH), and 3) an FSH level of 25 mIU/ml (high FSH) (Fig. 1) .
Increase and continuous decrease in FSH concentrations were considered in order to mimic superovulation and physiological conditions, respectively. When FSH doses are injected at the start of stimulation, FSH concentrations increase moderately in serum and in follicle fluid by a factor of 3 to 4 [22] . During a normal cycle, however, FSH concentrations in serum and follicular fluid decrease because of the physiological downregulation of pituitary FSH production [21] . A continuous decrease in FSH was obtained by refreshing with culture media without FSH from Day 6 onward. In this case, we exposed follicles to final FSH doses of 6 mIU/ml (on average) from Day 6 to Day 9 and 3.6 mIU/ml (on average) from Day 9 to Day 12. Increase in FSH exposure was achieved by increasing FSH concentrations in the refreshment medium at a dose of 47.5 mIU/ml to obtain 25 mIU/ml from Day 6 and maintaining that concentration up to Day 12. At least 70 follicles were assessed in each FSH condition and each developmental stage (Day 8 or Day 12).
Follicle-enclosed COCs were isolated from follicles at two different developmental stages, Day 8 and Day 12 of culture. Germinal vesicle-stage (GV) oocytes were washed carefully and completely denuded by repeated pipetting using a mouth-controlled hand-drawn Pasteur pipette. Zona pellucida was dissolved as previously described [24] . Oocytes and their corresponding cumulus cells were collected and frozen in groups of five and kept at À808C. Messenger mRNA levels of Gdf9, Bmp15, and Fgf8 in the oocyte and of Amh, Ar, and Lhcgr in their corresponding cumulus cells were quantified by real-time PCR.
Adult mice (9 wk old) stimulated for 48 h with equine chorionic gonadotropin (eCG) were used to collect in vivo GV oocytes. In short, the largest antral follicles in the ovaries were punctured, and COCs were isolated and washed in Leibovitz medium. Oocytes were denuded, freed of the zona pellucida, and finally frozen for gene expression analysis.
In two independent experiments, follicles were stimulated, on Day 8 and Day 12, by the addition of human chorionic gonadotropin (hCG) (1.2 IU/ml; Ares-Serono, Rockland, MA) plus 0.65 nM recombinant human epidermal growth factor (Roche Diagnostics, Mannheim, Germany) in the refreshment medium. Oocyte meiotic competence was assessed after 16 h of stimulation.
RNA Isolation and RT
Total RNA isolation and RT were carried out as described previously [24] . RNA was isolated from at least six pools of five oocytes or cumulus cells (per condition) using the RNeasy Micro Kit (Qiagen, Studio City, CA). Before RNA extraction, each oocyte sample was spiked with 10 pg of the exogenous control Luciferase (Promega, Madison, WI) to compensate for variations among samples due to the RNA extraction and RT procedures. This step was omitted for cumulus cells because 18S ribosomal RNA was used for normalization. In order to remove any possible residual genomic DNA, a DNase step was included. RNA was eluted from the silica-based extraction column in 14 ll of RNase-free water.
Reverse transcription was performed using TaqMan RT Reagents (Applied Biosystems, Foster City, CA). Total RNA from the pools of oocytes and cumulus was reverse transcribed. Twelve microliters of each RNA sample was primed with 2.5 ll of random hexamers (50 lM), 7.25 ll of water, 5 ll of 103 RT buffer, 11 ll of MgCl 2 (25 mM), 10 ll of deoxynucleotide triphosphate (2.5 mM), 1 ll of RNase inhibitor (20 U/ll), and 1.25 ll of Multiscribe RT (50 U/ ll; Applied Biosystems) in a total volume of 50 ll. The PCR conditions were 10 min at 258C, 30 min at 488C, and 5 min at 958C. As negative controls, addition of water instead of RNA was used in the first negative sample, while addition of RNA in a similar mixture was used as the second negative sample but without Multiscribe RT.
Quantitative Real-Time PCR
Absolute RNA quantification was performed in a Light Cycler device (LC-480; Roche Diagnostics) using Probes Master Mix (Roche Diagnostics) for oocyte transcripts as previously described [24] but adjusted to a smaller final volume. Briefly, 2 ll of each cDNA sample was processed in a total reaction volume of a 15-ll mixture containing 7.5 ll of Probes Master Mix, 1.5 ll of a forward (9 lM) and reverse (9 lM) primer mix, 0.15 ll of specific probes (10 lM), and 3.85 ll of nuclease-free water. For cumulus cell transcripts, quantification was carried out using SYBR Green PCR Master Mix (Roche Diagnostics) in a total reaction volume of 15 ll consisting of 2 ll of cDNA, 7.5 ll of SYBR Green Master Mix, 1.5 ll of a forward (9 lM) and reverse (9 lM) primer mix, and 4 ll of nuclease-free water. The real-time PCR protocol using Probes Master Mix was as follows: 10 min at 958C, followed by 50 cycles at 958C for 10 sec and 608C for 30 sec, and then a cooling step at 48C. When SYBR Green Master Mix was used, PCR conditions were the same as already described and were followed by a melting curve. For Amh, a primer concentration of 1 lM and 46 cycles were used. For each oocyte and cumulus sample, PCR reactions were carried out in triplicate. Primers were designed 
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using the Universal Probe Library (Roche Diagnostics), and their sequences are given in Table 2 . Primer sequences of oocyte genes and 18S ribosomal RNA were identical to those used by Sánchez et al. [24] . Standard curves were constructed using 10-fold serial dilutions of a gene-specific synthetic oligo. A negative control consisted of 13 ll of PCR mix and 2 ll of nuclease-free water instead of the cDNA sample. Standard dilutions and a negative control were included in each reaction plate. Oocyte transcripts are normalized to the amount of exogenous control and the number of oocytes and are presented relative to the average expression on Day 12 from the control condition (calibrator). Cumulus cells are normalized to the amount of the endogenous control Rn18s and are presented as the gene:Rn18s ratio.
Response to hCG in Cumulus Cells Expressing Lhcgr
Because the presence of Lhcgr expression in cultured cumulus cells was demonstrated, two extra follicle cultures were carried out to test the luteinizing hormone (LH) response in cumulus cells. In brief, the setup of the culture was performed as already described, with treatments (decrease and increase in FSH) starting on Day 6 until the end of culture. Cumulus-oocyte complexes grown under the three different FSH conditions (control, low FSH, and high FSH) were retrieved from Day 12 antral follicles. After being thoroughly rinsed, COCs were cultured in 50 ll of their corresponding FSH medium in the presence or absence of hCG (1.2 IU/ml) during 12 h. Six groups comprising 10 COCs of a homogeneous size were analyzed in each condition. After 12 h of culture, cumulus expansion was assessed, and cumulus cells were frozen for gene expression analysis of the activated leukocyte cell adhesion molecule (Alcam) and Versican (Vcan) to witness response to hCG. Messenger RNA quantification of both transcripts was analyzed on cumulus cells of the two extreme conditions (low FSH and high FSH) and was performed as already described. In this case, however, the primer concentration of both genes was 6 lM ( Table 2) .
Measurement of Progesterone Secretion
Progesterone secretion was measured in the following samples: 1) conditioned media collected from the complete follicles grown under the three FSH treatments at Day 9 and Day 12 (days of refreshment after the variable FSH treatment) and 2) conditioned media collected from COCs (from the three FSH treatments) 12 h after culture with or without hCG using a direct radioimmunoassay (Cisbio International, Gif-sur-Yvette, France). The analytical sensitivity of the assay is 0.01 lg/L, and the total imprecision profile is less than 10% coefficient of variation. In order to reduce variability to the minimum, all samples from COCs were analyzed in the same run.
Statistical Analysis
Data were analyzed using GraphPad Prism version 4.00 (GraphPad Software, San Diego, CA). D'Agostino and Pearson omnibus normality test was used to assess whether the data represented a gaussian distribution. Differences in the mean expression levels of oocyte and cumulus cells among the three FHS conditions, as well as for progesterone secretion of follicles, were assessed by ANOVA, followed by Tukey multiple comparisons test. Differences between Day 8 and Day 12 samples were assessed using Student t-test. Statistically significant differences in mRNA expression between oocytes or cumulus cells from each of the three FSH treatments compared with in vivo samples were assessed using Student t-test, followed by Bonferroni correction. In this case, differences were considered significant at P , 0.0166. Correlations were verified using Pearson product moment correlation analysis (a ¼ .05). Differences at P , 0.05 were considered significant unless otherwise indicated.
In the case of Amh, although most of the samples analyzed by real-time PCR showed a melting peak corresponding to this transcript, some samples had cp values that fell outside the range of the standard curve. Therefore, it was decided to designate those samples as being nonquantifiable. However, for 
RESULTS
Effect of Variable FSH Concentrations During the Antral Stage of Follicle Culture
Follicle and oocyte development. The use of variable FSH doses from Culture Day 6 did not have an impact either on the formation of the antral-like cavity or in the final follicle survival rate. Modest changes were noticed in follicle morphology such as a larger mass of granulosa cells under the high-FSH condition or a slightly smaller follicle size under the low-FSH condition by the end of culture (Fig. 2 ).
There were no differences in the mean 6 SD diameters of oocytes under the three FSH conditions at any of the two developmental stages analyzed (72.2 6 2.9 lm on Day 8 and 73.7 6 2.9 lm on Day 12). Meiotic resumption was similar under the three FSH conditions: 66% and 98% (on average) at 16 h after hCG stimulus on Day 8 and Day 12, respectively.
Progesterone production by cultured follicles. Follicleconditioned media were collected at Refreshment Days 9 and 12. Progesterone secretion was measured in samples from the three different conditions. On Day 9, there were no differences in progesterone secretion among the three conditions; however, samples from the high-FSH group produced two times more progesterone than samples from the low-FSH group. On Day 12, progesterone levels were significantly increased under high FSH compared with under low FSH (P , 0.05) (Fig. 3) .
Effect of Variable FSH Doses During the Antral Stage on Gene Expression in Oocytes and Cumulus Cells
Changes in mRNA expression in oocytes. In oocytes, Bmp15, Gdf9, and Fgf8 mRNA expression on Day 8 of culture was similar under the three FSH conditions, although there was a tendency for the three genes to increase (shown by one third of the samples) under high-FSH concentrations at this stage (Fig. 4, left panels) . On Day 12 of culture, the amounts of Bmp15 and Gdf9 transcripts were significantly increased 1.6-fold to 2-fold (P , 0.05) after exposure to high compared with the other two conditions (Fig. 4, a and b, right panels) . Fgf8 levels were also significantly increased ;1.5-fold (P , 0.05) in high FSH but only compared with the low-FSH condition (Fig.  4c, right panel) . Remarkably, low-FSH concentrations had no effect on gene expression compared with in vivo control.
Bmp15 and Gdf9 mRNA expression significantly decreased from Day 8 to Day 12 of culture under low FSH and control FSH (P , 0.005 and P , 0.01, respectively). These results are shown in Figure 4 , a and b.
When in vivo expression levels of the three genes were compared with each of the in vitro conditions at both 
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developmental stages analyzed, no differences in mRNA amount were found, with the exception of Bmp15, for which mRNA levels on Day 8 under low FSH were significantly higher compared with expression in in vivo oocytes (P , 0.0166). These results are shown in Figure 4a .
Changes in mRNA expression in cumulus cells. In cumulus cells, Amh expression levels on Day 8 did not vary among the three FSH treatments (Fig. 5b) . By Day 12, exposure of follicles to high FSH caused a drop in Amh signal to values below quantifiable levels in 80% of the cumulus samples analyzed (Fig. 5a ). Despite this clear decrease (;3-fold to 4-fold), the mean expression levels of Amh were not statistically significant different compared with the other conditions (Fig. 5c) . Amh mRNA expression from Day 8 to Day 12 decreased under the three FSH conditions (Fig. 5, b and  c) . Conversely, as shown in Figure 5 (d and e) , Lhcgr mRNA levels considerably increased in the presence of high FSH compared with low-FSH and control-FSH conditions both on Day 8 (4-fold increase) and Day 12 (4-fold to 18-fold increase) (P , 0.001). Notably, while Lhcgr levels increased from Day 8 to Day 12 under control FSH (P . 0.05) or high FSH (P , 0.01), Lhcgr mRNA expression was significantly reduced in the low-FSH condition (P , 0.005) (Fig. 5, d and e) . Although a correlation between Amh and Lhcgr expression values in cumulus cells could not be found, it was nevertheless clear that, in most of the samples with no quantifiable Amh levels, Lhcgr mRNA expression was higher than in other samples.
Expression levels of Pfkp transcript were not found to be different under the three FSH treatments on Day 8 or Day 12 of culture. Nonetheless, an increase from 1.6-fold to 2.6-fold in Pfkp expression levels was found on Day 12 compared with Day 8 (low-FSH condition, P , 0.05; control-FSH and high-FSH conditions, P , 0.005) (Fig. 6, a and b) .
On Day 8, cumulus Ar mRNA expression significantly increased under high FSH compared with the control FSH (P , 0.05) but not compared with the low-FSH condition. By Day 12, treatment with high FSH was again found to upregulate Ar levels, ;1.6-fold to 1.8-fold, compared with both of the other conditions (P , 0.01) (Fig. 6, c and d) .
Under in vivo conditions, Amh expression was found to be much higher (20-fold to 300-fold) compared with all in vitro conditions, irrespective of the day of development (Day 8 or Day 12) and was most pronounced compared with the high-FSH condition (P , 0.0001) (Fig. 5, b and c) . On the other hand, Lhcgr mRNA expression was found to be considerably lower (3-fold to 54-fold) in in vivo cumulus cells compared with in vitro (P , 0.001), with the exception of samples under low FSH on Day 12 of culture (Fig. 5, d and e) .
Pfkp transcript levels in in vivo cumulus cells were also found to be 2.3-fold to 3.5-fold higher compared with in vitro cumulus cells from Day 8 (irrespective of the FSH treatment) (P , 0.0166 after Bonferroni correction) but constant in expression levels compared with samples from Day 12 (Fig. 6,  a and b) . Finally, amounts of Ar mRNA were 1-fold to 2-fold higher under in vivo conditions compared with expression under low FSH and control FSH (either on Day 8 or Day 12) but not compared with samples exposed to high FSH (P , 0.0166) (Fig. 6, c and d ).
Cumulus Expansion, Progesterone Production, and Ovulation Gene Effects of hCG on Cumulus Cells Expressing Lhcgr
Given that Lhcgr mRNA was demonstrated to be expressed in cultured cumulus cells and that its expression was significantly increased under high FSH, the ability of Lhcgr to generate a response under hCG stimulus (1.2 IU) was determined. Because in this culture model a notable increase in follicular progesterone levels is reached from 8 h after hCG stimulus [25] , COCs were cultured for 12 h in order to generate a measurable response. Cumulus-oocyte complexes from Day 12 follicles (expressing the highest amounts of Lhcgr mRNA) exposed to the different treatments were cultured in the presence or absence of hCG. After 12 h, cumulus expansion was scored as described by Vanderhyden et al. [26] . The COCs cultured without hCG showed a minimal (þ1) response in the groups with control FSH and high FSH; COCs from the low-FSH condition, however, did not respond. With hCG present in the medium, COCs from the control-FSH and high-FSH conditions showed a clear response (þ1 to þ2), with a glistening appearance and expansion in the outer layer of cumulus cells. Interestingly, COCs grown under decreased FSH concentrations did not show any response to hCG trigger (Table 3 and Fig. 7 ). As expected, progesterone measurement was low in all conditions given that cumulus cells are only minor producers of progesterone compared with mural granulosa cells in this follicle culture model. It is noteworthy that progesterone secretion by COCs grown under high-FSH concentrations was significantly increased compared with both control-FSH (P , 0.05) and low-FSH (P , 0.001) conditions, and this was irrespective of the hCG stimulus (Fig. 8, left  panel) . In the presence of hCG, the progesterone increase was higher, especially compared with the low-FSH condition (3.6-fold) (Fig. 8, right panel) . Progesterone secretion in COCs grown under high FSH was two times higher (P , 0.0003) in the presence of hCG (Fig. 8) .
To complement observations on progesterone, mRNA amounts of Alcam and Vcan were quantified in cumulus cells from COCs grown under the two ''extreme'' conditions (low FSH and high FSH) after 12-h culture in the presence or absence of hCG. In COCs not stimulated with hCG, levels of Vcan were similar under both FSH exposures. Under hCG stimulus, cumulus cells from the high-FSH condition expressed double the amount of Vcan compared with the low-FSH condition (P , 0.005) (Fig. 9) . Alcam mRNA levels were significantly lower in samples grown under low FSH compared with high FSH both in the presence and absence of 12-h hCG stimulus (P , 0.01 and P , 0.005, respectively). Under the high-FSH condition, the hCG stimulus was capable of doubling the levels of Alcam (P , 0.01) (Fig. 9) . Alcam and 
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Vcan mRNA levels positively correlated with progesterone production (r ¼ 0.79 and r ¼ 0.75, respectively; P , 0.0001).
DISCUSSION
Follicle Survival and Antrum Formation under Different FSH Treatments
Follicle-stimulating hormone induces proliferation and differentiation of granulosa cells; it is an essential factor for follicle survival in vivo and in vitro and induces antrum formation and estrogen production in vitro [16, 23] . Absence or suboptimal concentrations of FSH from earlier stages of follicle development are not compatible with normal follicle development in vitro, as these were shown to limit antrum formation [27] [28] [29] . In this follicle culture model, exposure to a minimally effective dose of FSH (10 mIU/ml) from the earliest in vitro preantral stages is also required for proper oocyte developmental competence [23] . In the present study, follicles were grown under control-FSH conditions until the day of initiation of antrum formation, which is Day 6 of culture in this model [24, 30] . Three different FSH regimens were applied from Day 6 until the end of culture, namely, low FSH, control FSH, and high FSH. Observations showed that further progression of antral development, maximum oocyte diameter, and meiotic resumption were equally achieved in follicles under all FSH conditions. However, the endocrine environment progressively shifted with differences in FSH exposure time; significantly higher progesterone secretion was induced by high FSH. Increased basal progesterone production could be seen as a negative sign of follicle health [31] . Therefore, high-FSH concentrations during the late antral phase seem to induce an altered follicle physiology.
Gene Expression in Cultured Oocytes and Cumulus Cells Exposed to Different FSH Regimens
The FSH concentration influences cross talk between oocyte and granulosa cells during the earliest development stages by modulating the expression of factors such as kit ligand by   FIG. 7 . Cumulus-oocyte complexes from Day 12 cultured follicles developed under the three FSH doses before and after stimulation with or without hCG for 12 h. Under low-FSH concentrations, COCs do not respond to the hCG stimulus; cumulus cells attach to the plate and proliferate well (arrowheads). The COCs from the control-FSH and high-FSH conditions show signs of expansion in the outer cell layers, mainly after hCG stimulus (arrows), and a few cells attached to the plate are shown. Bar ¼ 100 lm.
FIG. 8. Different responses in progesterone production (pg/COC) from
COCs grown under the three different FSH conditions and stimulated for 12 h with or without hCG. Statistical differences in progesterone secretion among the three FSH conditions are indicated by different lowercase letters and capital letters in the absence and presence, respectively, of hCG. Irrespective of the hCG stimulus, COCs in the high-FSH condition produced significantly higher progesterone levels than in the control-FSH and low-FSH conditions (P , 0.05 and P , 0.001, respectively, ANOVA). *Indicates differences in progesterone levels within the same FSH condition in response to hCG (P , 0.0003, Student t-test). [26] .
Treatment 12 Hours
ÀhCG þhCG
Low FSH 0 0 10 mIU FSH þ1 þ1 to þ2 25 mIU FSH þ1 þ2 520 granulosa cells, which have a positive impact on the oocyte [32] . The effects of different FSH doses administered during the antral period of in vitro growth on gene expression in oocytes and cumulus cells have not been extensively studied. Oocyte Gdf9, Bmp15, and Fgf8 and cumulus cell Amh, Ar, Lhcgr, and Pfkp mRNA were quantified at the following two time points: at Day 12, when fully grown follicles contain 80% of nuclear-competent oocytes [33, 34] , and at Day 8, when relative mRNA levels of key oocyte transcripts were demonstrated to be comparable to in vivo levels [24] (although follicles contain 63% of nuclear-competent oocytes [30] ). In this culture system, fertilized in vitro Day 8 oocytes were found to produce a higher proportion of 2-cell-stage embryos compared with those on Day 12 [30] .
Gene Expression in Cultured Oocytes
GDF9, BMP15, and FGF8 are three oocyte-secreted factors required for follicle development and differentiation; they are also required for oocyte growth, maturation, and acquisition of developmental competence [3, 6, 7, 9, 10, [35] [36] [37] [38] [39] .
In this study, we report for the first time to date that FSH at a concentration 2.5 times higher than the minimally effective dose (25 vs. 10 mIU/ml) results in significant ;2-fold upregulation of the expression levels of Gdf9, Bmp15, and Fgf8 transcripts by Day 12 (after 6 days of exposure), with a tendency detectable as early as Day 8. Guéripel et al. [19] demonstrated that treatment of immature mice with recombinant human FSH for 48 h and 72 h caused an increase in Bmp15 mRNA levels. Conversely, however, Bmp15 transcript levels have been shown to be downregulated in oocytegranulosa cell complexes treated with FSH [32] . In both of these studies, Gdf9 mRNA expression was unaffected by FSH. Discrepancies in the results may, however, be explained by the different in vitro/in vivo environments, the FSH doses applied, and, importantly, the stage of follicular development (preantral or antral) at which the samples were collected.
In a previous publication, we reported that under an FSH level of 10 mIU/ml both Bmp15 and Gdf9 mRNA amounts decreased across culture time parallel with oocyte transcriptional silencing [24] . In the present study, Gdf9 and Bmp15 transcript levels dropped significantly from Day 8 to Day 12 under both low-FSH and control-FSH conditions but not under high-FSH tonus, probably because values tended to be higher as early as Day 8 and significantly so on Day 12 (Fig. 4) . Considering the present data, elevated FSH tonus may have implications in the expression pattern of these genes, disturbing their decline over time. This point might be relevant in conventional step-up FSH ovarian stimulation protocols for human ART, in which high-FSH doses accumulate in the follicle, while FSH concentrations are low (by estrogen feedback) in the natural cycle [21, 22] . Under decreasing FSH tonus, which might be analogous to clinical situations in which FSH administration is withheld after minimal initial administration (so-called step-down stimulation regimens), the normal drop-off and levels of transcripts analyzed do not seem to be affected and are consistently similar to the control-FSH condition in the present study. Further explanation of these results is given herein.
Gene Expression in Cumulus Cells
Oocytes control follicle development through the secretion of paracrine factors, including GDF9 and BMP15, by regulating several functions in the granulosa cells such as granulosa cell proliferation, differentiation, and maintenance of cumulus cell phenotype [4, 6, 7, [40] [41] [42] . Follicle-stimulating hormone has been shown to regulate expression of specific transcripts in granulosa cumulus cells [5, 15, 18, 43] . We also analyzed the mRNA expression levels of oocytes matching cumulus cell transcripts (Amh, Ar, Pfkp, and Lhcgr). Amh mRNA is highly expressed in granulosa cells from preantral follicles, but after follicle differentiation it is maintained in higher levels in cumulus cells compared with mural cells [14, 44, 45] . Although a role of AMH in the inhibition of oocyte maturation was suggested [46] , this could not be further confirmed [47] . In the present study, Amh mRNA was detected in cultured cumulus cells, and their levels declined from Day 8 to Day 12 under low FSH and control FSH. Under high FSH, however, transcripts were so low that they could not be quantified in more than 80% of Day 12 samples. In rats, Amh was reported to be expressed in preantral and small antral follicles, while it was found in low levels in large antral follicles [44] . Our results concur with the latter findings and are EFFECT OF FSH DOSES DURING IN VITRO ANTRAL GROWTH also in line with Diaz et al. [5] , who reported an inhibition of Amh expression in cumulus cells after 10 days' culture of preantral oocyte-granulosa cell complexes with an FSH level of 25 mIU/ml. Lhcgr transcripts in the high-FSH group herein were found to be increased 4-fold to 18-fold by Day 8 and Day 12 compared with the low-FSH condition. Lhcgr is a marker of mural cell phenotype, and its expression is stimulated by FSH [17, 43, 48] . In animal models other than mouse, the presence of Lhcgr in cumulus cells was detectable and upregulated by FSH [15, 49, 50] ; however, partial or absent Lhcgr mRNA expression has been reported in mouse COCs from preovulatory follicles [17, 48, 51] . In mouse, upregulation of Lhcgr mRNA in intact follicles grown under a three-dimensional configuration correlates with high antrum formation, oocyte fertilization, and blastocyst rates [52] ; under regular twodimensional organization, abnormally increased Lhcgr levels in cumulus cells compromised oocyte developmental competence [18] . These results are not contradictory because upregulated Lhcgr levels in the intact follicles are the product of granulosa and theca Lhcgr expression, which is essential in triggering ovulation [31, 52] . However, upregulation of Lhcgr in differentiated cumulus cells predicted poor oocyte quality [18] .
Although no significant correlation between Amh and Lhcgr expression in cumulus cells was found, most of the in vitro cumulus samples below the quantification level for Amh demonstrated higher Lhcgr expression levels. Therefore, low levels of Amh, considered an inhibitor of Lhcgr expression [53] , may be partly responsible for elevated levels of Lhcgr in corresponding samples.
Oocyte signals and FSH have opposite effects within the antral follicle [43] . Oocytes, through their secreted factors, stimulate the expression of transcripts such as Amh [5, 13, 14] , Ar [43] , and Pfkp [12] , whereas they suppress Lhcgr expression in cumulus cells, even in the presence of FSH (as also demonstrated using recombinant GDF9) [5, 17, 41, 54] . Gene expression in oocytes from the high-FSH condition herein led to a significant increase in Gdf9 and Bmp15 mRNA amounts by Day 12 of culture. Because of the known role of the oocyte in maintaining proper cumulus cell phenotype, elevated Gdf9 and Bmp15 transcript levels might be seen as a response effect to an altered differentiation pattern in cumulus cells given by increased FSH concentrations, an effect apparently amplified by the extent of FSH exposure and the duration of culture.
Transcript levels of Amh and Lhcgr measured in vitro (irrespective of the FSH conditions) were significantly lower and higher, respectively, compared with in vivo, with the only exception being Lhcgr levels in the low-FSH condition on Day 12, which did not differ (this was due to a significant decrease rather than an increase from Day 8 to Day 12). A possible explanation may be that under in vivo conditions follicles grow under a closed three-dimensional organization, whereas under the present in vitro conditions, follicles grow in a twodimensional structure (in an ''open system'') without the boundary of a basal membrane and without an intact follicle wall. We suggest that oocyte-secreted factors such as GDF9 and BMP15 might have become diluted, influencing cumulus cell key transcript expression levels. Amh levels were still low under low-FSH concentrations; nevertheless, low Lhcgr expression could be maintained, suggesting that a decrease in FSH during the antral phase (as in in vivo conditions) to some extent sustains the appropriate cumulus cell phenotype.
Analysis of Pfkp and Ar demonstrates that FSH does not seem to have an effect on the expression of Pfkp transcript during the antral stage but upregulates Ar levels. Because of their abundance in cumulus cells compared with mural cells, both Pfkp mRNA and AR mRNA and protein expression were proposed as cumulus cell markers [12, 43, [55] [56] [57] . Based on its expression pattern in the follicle, AR has been attributed a role in controlling local mechanisms throughout folliculogenesis under the control of oocyte-secreted factors [58] . Regulation of Ar mRNA expression in rat and mouse ovary and granulosa cells was shown to decrease with FSH treatment [43, 59] . Our results, however, show that under the present culture conditions high-FSH concentrations upregulate Ar levels both on Day 8 and Day 12 of culture. These contradictory results might be explained by the different FSH concentrations/preparations used, the different development stages, and the samples analyzed. In vivo Ar mRNA levels were higher compared with the in vitro control-FSH and low-FSH conditions but achieved levels similar to those of cumulus cells cultured under high-dose FSH conditions, irrespective of the stage of in vitro development.
Regulation by FSH of Pfkp, a key gene involved in glycolysis, has not been previously investigated; however its mRNA levels are known to be stimulated by oocyte-secreted factors [8, 12] . In vivo Pfkp levels were increased compared with all in vitro treatments on Day 8 but were similar to those of samples analyzed on Day 12. In conclusion, results based on these two transcripts indicate that, compared with previous results based on Amh and Lhcgr, in vitro-produced cumulus cells are capable of expressing Pfkp and Ar transcripts at levels comparable to in vivo.
Differences in Cumulus Cell Lhcgr Expression Induced by Variable FSH Exposures Result in Differential Responses
In order to demonstrate the functionality of Lhcgr expressed in the cumulus cells and the differences in response between FSH treatments (given that mRNA levels were differently expressed under low FSH and high FSH), COCs from Day 12 follicles were stimulated with or without hCG. Triggering ovulation by LH/hCG is associated with COC matrix formation. Cumulus expansion, assessed after 12-h culture, demonstrated differences depending on the FSH concentration under which COCs differentiated during culture. Under control FSH and high FSH, COCs reacted to the hCG triggering, showing signals of cumulus expansion, while COCs grown under decreasing FSH concentrations did not. The amounts of two cumulus cell transcripts that are downstream of the LH signaling and related to cumulus expansion were measured in the two extreme conditions (low FSH and high FSH). Versican is a secreted extracellular matrix proteoglycan associated with formation of the COC matrix [60] . Alcam codes for an extracellular matrix-related protein, and its role in enhancing cell adhesion to the COC matrix has been suggested [61] . In mice, Vcan mRNA and Alcam mRNA are known to be expressed 12 h after hCG stimulus [61, 62] , so their levels could be measured and compared in this experimental setup. Alcam and Vcan transcripts were significantly higher expressed in COCs grown under high FSH compared with low FSH after 12-h hCG stimulus, while only Alcam was also highly expressed in COCs from the high-FSH condition after 12 h without hCG stimulus. Notably, in accord with cumulus expansion response, Alcam was shown to be upregulated in response to hCG only in COCs grown under high-FSH concentrations. Higher-FSH levels also resulted in higher progesterone secretion 12 h after hCG stimulus and even in the absence of hCG (3.7-fold and 2.5-fold increases, respectively) compared with the low-FSH condition. Consistent with the findings in morphology and gene expression, only COCs grown under high FSH responded to hCG stimulus by doubling 522 progesterone concentration. Levels of Alcam and Vcan mRNA positively correlated with progesterone production.
Eppig et al. [18] demonstrated that follicles grown during 10 days under different FSH concentrations developed functional Lhcgr in cumulus cells, while follicles grown without FSH or from in vivo did not, suggesting an inappropriate cumulus cell differentiation in the presence of minimal amounts of FSH. In this study, results observed under high FSH concur with the findings by Eppig et al. [18] ; applying decreasing FSH concentrations during the antral growth period, however, not only diminished the amount of Lhcgr expressed in cumulus cells but also demonstrated that no response to hCG could be generated.
In conclusion, gene expression in oocytes and corresponding cumulus cells is influenced by minor changes in FSH exposure levels during the antral stage of follicle development. Of particular interest is the fact that Amh and Lhcgr mRNA expression seems to be very sensitive to a combination of in vitro culture plus increased FSH tonus, while this is less the case with Pfkp and Ar. Increasing FSH concentrations during antral growth induce functional Lhcgr mRNA in cumulus cells, leading to abnormal cumulus functionality. Under the studied FSH regimens, oocyte Gdf9 and Bmp15 expression might be regulated to compensate for some dysregulation in corresponding cumulus cells. Modulating the mode of delivery of near physiological FSH concentrations can result in a differentiation pattern of critical transcripts that is closer to normal in vivo patterns. Further investigations on the mode of delivery of major growth factors to oocyte culture systems might improve oocyte developmental competence.
